Skip to main content
Caplight Logo









Qkine

Qkine

Private
CambridgeHealthcare & Life Scienceshttps://qkine.com/

Last Round

VC Round

Mar 21, 2025

Total Funding Raised

$3.15M

Company Overview

Qkine is a biotechnology company that manufactures high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell and organoid culture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

recombinant proteinsgrowth factorsanimal-free reagentscell therapy reagentsbioprocessingGMP reagentsstem cell researchcytokinesorganoid developmentgood manufacturing practiceGMPbiomanufacturinglab reagentsbiotech supply chaincustom protein production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qkine Comparables

Compare Qkine with similar companies based on industry and business-model similarity.

Qkine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ORF Genetics
81%
Core Biogenesis
80%
Akron Biotech
78%

Qkine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 21, 2025
DebtDec 19, 2022
VC RoundDec 15, 2022
Series AJun 8, 2020
SeedJun 3, 2019
Seed
Apr 23, 2018

Qkine Investors

Notable investors and investment history

Qkine investors
InvestorRounds
Innovate UKDebt
o2h venturesVC Round
Cambridge EnterpriseSeed, Series A
Downing VenturesVC Round
Parkwalk AdvisorsVC Round, Series A
Oxford Innovation FinanceVC Round
Martlet CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Launched QkPlate (C), pre-prepared dried vitronectin-coated plates.

  • Mar 23, 2026

    Developing QkPlate (C) human vitronectin coated plates.

Qkine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qkine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qkine's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range35
Year Founded2016
Last FundingMar 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?